Carpenter D, Grimmer J, Lomazoff E. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation”. Regulation and Governance . 2010;4 (4).

Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review. Journal of Law Economics and Organization . 2010;26 (2).

Carpenter D. “Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration”. Perspective on Politics. 2010;8 (3) :825-46.

Carpenter D. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation”. Public Choice and Public Law . 2010.

Carpenter D, Grimmer J. The Trouble with Deadlines. 2009. downside.pdf

Carpenter D, Balleisen E, Moss D. “Confidence Games: How Does Regulation Constitute Markets?”. In: Towards a New Theory of Regulation. New York : Cambridge University Press ; 2009.

Carpenter D, Kazin M. “Regulation”. In: The Princeton Encyclopedia of Political History . ; 2009.

Carpenter D, Volden C, Ting M. “A Formal Model of Learning and Policy Diffusion” . American Political Science Review . 2008;102 (3) :319-32.

Carpenter D, Zucker EJ, Avorn J. Drug Review Deadlines and Subsequent Safety Problems. New England Journal of Medicine . 2008;358 (13) :1354-61.

Carpenter D, Bowers J, Grimmer J, Moffitt S, Nall C, Zucker EJ. Deadline Effects in Regulatory Review: A Methodological and Empirical Analysis. 2007. deadline-methods-pdufaclock-nomedjournalfigsortables-20070723.pdf

Carpenter D, Grimmer J. Dynamic Stochastic Learning in Regulatory Optimization: Deadlines and Error with Continuous and Discrete Evidence. 2007. deadline-theory-2007.pdf

Carpenter D. “The Leaning Tower of PISA: Fundamental Problems in Ignorance-Based Theories of State Autonomy” . Critical Review . 2007.

Carpenter D, Sin G. “Policy Tragedy and the Emergence of Regulation: The Food Drug and Cosmetic Act of 1938”. Studies in American Political Development . 2007;21 (2) :149-180.

Carpenter D, Ting M. “Regulatory Errors with Endogenous Agendas”. American Journal of Political Science . 2007;51 (4) :835-853. regulatory_error_with_endogenous_agendas_-_ajpspublished.pdf

Carpenter D, Moore CD, Glassman M, Skowronek S. “Robust Action and the Strategic Use of Ambiguity in a Bureaucratic Cohort: FDA Scientists and the Investigational New Drug Regulations of 1963”. Formative Acts: American Politics in the Making . 2007.

Carpenter D. “Reputation Gatekeeping and the Politics of Post-marketing Drug Regulation”. Virtual Mentor [American Medical Association] . 2006;8 :403-406. Publisher's Version

Carpenter D, Armstrong E, Hojnacki M. “Whose Deaths Matter? Mortality Identity and Attention to Disease in the Mass Media”. Journal of Health Politics Policy and Law . 2006;31 (4) :729-772.

Carpenter D. A Simple Theory of Placebo Learning with Self-Remitting Conditions. 2005. placeboremit.pdf

Carpenter D, Ting M. “The Political Logic of Regulatory Error” . Nature Reviews – Drug Discovery . 2005;4 (10) :819-823.

Carpenter D. “A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees” . Health Affairs – Web Exclusive . 2005;W5 (469).